News & Views
Lung cancer drug 'could prevent metastases spreading'
Feb 25 2011
Dr Michela Quirino and colleagues from the Catholic University of the Sacred Heart in Rome announced the laboratory news after investigating how zoledronic acid may be able to prevent the cancer from spreading.
Currently, the drug is used to help treat bone metastases but the study suggests it may also be useful in the initial stages of the disease.
Dr Quirino said: "If further studies should confirm a possible anti-metastatic effect of this drug ... it could be introduced in the early management of the disease, even as an adjuvant therapy."
The expert conducted a trial on 41 patients with advanced lung cancer and concluded that the evidence implies zoledronic acid may prevent the metastases from recruiting the blood vessels they need to survive.
Zoledronic acid is also used to treat high levels of calcium in the blood.
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Nov 27 2024 Istanbul, Turkey
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE